ICH E2E Pharmacovigilance Guideline

The ICH E2E Pharmacovigilance Guideline provides international standards for monitoring the safety of medicines throughout their lifecycle. It outlines systematic processes for collecting, assessing, and reporting data on adverse effects experienced by patients. The goal is to ensure that any risks associated with medicines are identified promptly, enabling regulators and companies to protect public health. By following these guidelines, healthcare stakeholders can maintain consistent and reliable safety practices across different countries, helping to minimize harm while allowing patients to benefit from new and existing medications safely.